Roop Mallik, Professor in the Department of Biosciences and Bioengineering at the Indian Institute of Technology Bombay (IIT Bombay), was elected an Associate Member of the European Molecular Biology Organization (EMBO).
He is the fifth Indian scientist and the only one from IIT Bombay to join the life sciences community.
This year he is the only Indian of nine associate members elected to the EMBO.
“It’s recognition of the hard work and talent of my students and staff. I am glad that you have decided to work with me. Together we have always believed that we can do as well as our colleagues around the world, ”said Mallik, who is also a Senior Fellow of the India Alliance, funded by the Department of Biotechnology (DBT), the Government of India and Wellcome Will Trust, United Kingdom.
EMBO is an organization of over 1,800 leading researchers in the life sciences in Europe and beyond. The organization aims to support talented researchers at all stages of their careers, encourage the exchange of scientific information, and build a research environment in which scientists can perform at their best.
“It (EMBO membership) will give us visibility and better connect us with scientists working outside of India. This is very important for the advancement of science in our country and across borders, ”added Mallik.
This year EMBO added 64 life scientists to its growing membership roster. In a statement, EMBO said the 64 newly elected members live in 21 countries: 55 new EMBO members live in the member states of the EMBC, the intergovernmental organization that funds major EMBO programs and activities. Nine new EMBO Associate Members live in Argentina, Australia, India, Japan and the USA. 26 of the new EMBO members (41%) are women.
“I am happy to welcome the new members to our association and look forward to working with them. With the election for EMBO membership, outstanding achievements in the life sciences are recognized. The new members will provide expertise and guidance that will help EMBO further strengthen its initiatives, ”said Maria Leptin, Director of EMBO.